Lirum Therapeutics is an innovative biopharmaceutical company focused on the treatment of debilitating diseases.
Lirum Therapeutics has raised $7.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2023.
Lirum Therapeutics is headquartered in Newyork, United Kingdom.
Lirum Therapeutics is an innovative biopharmaceutical company focused on the treatment of debilitating diseases.
Lirum Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Lirum Therapeutics — Funding & Investors." VCBacked, February 8, 2023, https://www.vcbacked.co/company/lirum-therapeutics. Accessed November 14, 2026.
VCBacked. (2023). Lirum Therapeutics — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/lirum-therapeutics
{{cite web |title=Lirum Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/lirum-therapeutics |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Lirum Therapeutics? Request a listing update